UNTERSUCHUNGEN DER SAUREN FUNKTIONELLEN GRUPPEN VERSCHIEDENER 4-O-METHYLGLUKURONOXYLANPRAEPARATE = ETUDE DES GROUPES FONCTIONNELS ACIDES DE DIFFERENTES PREPARATIONS D'O-METHYL-4 GLUCURONOXYLANEEBRINGEROVA A; KRAMAR A.1975; CHEM. ZVESTI; CESKOSL.; DA. 1975; VOL. 29; NO 1; PP. 104-109; ABS. ANGL.; BIBL. 27 REF.Article

DEGRADATION THERMIQUE DES HEMICELLULOSES DE FEUILLUS AUX TEMPERATURES DE 80 A 200^OC. IV. STABILITE THERMIQUE DU 4-0-METHYLGLUCURONOXYLANE DANS UNE ATMOSPHERE D'AIR SECEBRINGEROVA A; KRAMAR A.1976; PAPIR A CELULOZA; CESKOSL.; DA. 1976; VOL. 31; NO 7-8; PP. V27-V30; ABS. ANGL. ALLEM. RUSSEArticle

CURE RATE ESTIMATION AND LONG TERM PROGNOSIS OF UTERINE CERVIX CARCINOMAPEJOVIC MH; WOLFF JP; KRAMAR A et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 1; PP. 203-206; BIBL. 16 REF.Article

ESSAI COMPARATIF RANDOMISE D'UN NOUVEL ANTI-EMETIQUE: LA NABILONE, CHEZ DES MALADES CANCEREUSES TRAITEES PAR LE CIS-PLATINUM = A COMPARATIVE RANDOMIZED TRIAL OF A NEW ANTIEMETIC COMPOUND: NABILONE IN CANCER FEMALES PATIENTS TREATED WITH CIS-PLATINUMGEORGE M; PEJOVIC MH; THUAIRE M et al.1983; BIOMEDICINE AND PHARMACOTHERAPY; ISSN 0753-3322; FRA; DA. 1983; VOL. 37; NO 1; PP. 24-27; ABS. ENG/FRE; BIBL. 15 REF.Article

ANALYZA A VYUZITIE HEMICELULOZ ODPADOVYCH LUHOV Z VYROBY VISKOZY = ANALYSE ET UTILISATION DES HEMICELLULOSES DES BASES RESIDUAIRES DE FABRICATION DE LA VISCOSEEBRINGEROVA A; KRAMAR A; SIMKOVIC I et al.1980; CHEM. VLAKNA; ISSN 0528-9432; CSK; DA. 1980; VOL. 30; NO 4; PP. 198-206; ABS. RUS/ENG; BIBL. 18 REF.Article

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumorsMASSARD, C; KRAMAR, A; BEYER, J et al.Annals of oncology. 2013, Vol 24, Num 2, pp 322-328, issn 0923-7534, 7 p.Article

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatmentSAMALIN, E; AFCHAIN, P; BOUCHE, O et al.Clinics and research in hepatology and gastroenterology (Print). 2011, Vol 35, Num 1, pp 48-54, issn 2210-7401, 7 p.Article

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors : a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)CULINE, S; KERBRAT, P; BIRON, P et al.Annals of oncology. 2007, Vol 18, Num 5, pp 917-924, issn 0923-7534, 8 p.Article

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancerAZRIA, D; LARBOURET, C; GARAMBOIS, V et al.British journal of cancer. 2003, Vol 89, Num 10, pp 1987-1994, issn 0007-0920, 8 p.Article

Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic filmsKRAMAR, A; TURK, S; VRECER, F et al.International journal of pharmaceutics. 2003, Vol 256, Num 1-2, pp 43-52, issn 0378-5173, 10 p.Conference Paper

Non-parametric methods for analysing recurrent complications of varying severityLANCAR, R; KRAMAR, A; HAIE-MEDER, C et al.Statistics in medicine. 1995, Vol 14, Num 24, pp 2701-2712, issn 0277-6715Article

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours : preliminary results of a French randomized trial. DiscussionCHEVREAU, C; DROZ, J. P; BOUZY, J et al.CHEVREAU, C; European urology. 1993, Vol 23, Num 1, pp 213-218, issn 0302-2838Conference Paper

Competing events determining relapse-free survival in limited small-cell lung carcinomaARRIAGADA, R; KRAMAR, A; LE CHEVALIER, T et al.Journal of clinical oncology. 1992, Vol 10, Num 3, pp 447-451, issn 0732-183XArticle

High-dose chemotherapy with ABMT in the first line treatment of poor risk non-seminomatous germ cell tumorsDROZ, J. P; PICO, J. L; BIRON, P et al.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 27Conference Paper

Randomised EORTC head and neck cooperative group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinomaRICHARD, J. M; KRAMAR, A; MOLINARI, R et al.European journal of cancer : (1990). 1991, Vol 27, Num 7, pp 821-827Article

Antimicrobial viscose fabric prepared by treatment in DBD and subsequent deposition of silver and copper ions—Investigation of plasma aging effectKRAMAR, A; PRYSIAZHNYI, V; DOJCINOVIC, B et al.Surface & coatings technology. 2013, Vol 234, pp 92-99, issn 0257-8972, 8 p.Article

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albuminPLOQUIN, A; OLMOS, D; VOEST, E. E et al.British journal of cancer. 2012, Vol 107, Num 7, pp 1025-1030, issn 0007-0920, 6 p.Article

SAE: An R package for early stopping rules in clinical trialsBASCOUL-MOLIEVI, C; LAPLANCHE, A; LE DELEY, M. C et al.Computer methods and programs in biomedicine (Print). 2011, Vol 104, Num 2, pp 243-248, issn 0169-2607, 6 p.Article

Analyse statistique des données de survieHILL, C; COM-NOUGUE, C; KRAMAR, A et al.2004, 190 p., isbn 2-257-12310-7Book

High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancerYCHOU, M; RAOUL, J. L; COUTEAU, C et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 5, pp 383-391, issn 0344-5704, 9 p.Article

Squamous cell carcinoma of the penis : Multivariate analysis of prognostic factors and natural history in a monocentric study with a conservative policySORIA, J.-C; FIZAZI, K; PIRON, D et al.Annals of oncology. 1997, Vol 8, Num 11, pp 1089-1098, issn 0923-7534Article

Plans expérimentaux pour l'inclusion de patients dans les essais de phase II = Statisticals designs for phase II trialsKRAMAR, A; POTVIN, D; HILL, C et al.Revue d'épidémiologie et de santé publique. 1996, Vol 44, Num 4, pp 364-371, issn 0398-7620Article

A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trialLAMBIN, P; GERBAULET, A; KRAMAR, A et al.European journal of cancer. Part A. 1994, Vol 30, Num 3, pp 312-320Article

Linear rank tests for comparing survival in two groups with crossing hazardsTUBERT-BITTER, P; KRAMAR, A; CHALE, J.-J et al.Computational statistics & data analysis. 1994, Vol 18, Num 5, pp 547-559, issn 0167-9473Article

Prognostic factors and natural history in lymph node-negative breast cancer patientsARRIAGADA, R; RUTQVIST, L. E; SKOOG, L et al.Breast cancer research and treatment. 1992, Vol 21, Num 2, pp 101-109, issn 0167-6806Article